Baker Avenue Asset Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-32,800
| Closed | -$489K | – | 1569 |
|
|
2023
Q3 | $489K | Sell |
32,800
-20,000
| -38% | -$298K | 0.02% | 264 |
|
|
2023
Q2 | $578K | Hold |
52,800
| – | – | 0.03% | 252 |
|
|
2023
Q1 | $460K | Hold |
52,800
| – | – | 0.02% | 272 |
|
|
2022
Q4 | $331K | Hold |
52,800
| – | – | 0.02% | 289 |
|
|
2022
Q3 | $185K | Hold |
52,800
| – | – | 0.01% | 322 |
|
|
2022
Q2 | $156K | Hold |
52,800
| – | – | 0.01% | 297 |
|
|
2022
Q1 | $164K | Buy |
+52,800
| New | +$164K | 0.01% | 282 |
|
|
2021
Q3 | – | Sell |
-52,800
| Closed | -$230K | – | 277 |
|
|
2021
Q2 | $230K | Hold |
52,800
| – | – | 0.01% | 223 |
|
|
2021
Q1 | $239K | Hold |
52,800
| – | – | 0.01% | 217 |
|
|
2020
Q4 | $303K | Sell |
52,800
-9,700
| -16% | -$55.7K | 0.02% | 198 |
|
|
2020
Q3 | $452K | Buy |
62,500
+15,000
| +32% | +$108K | 0.03% | 171 |
|
|
2020
Q2 | $166K | Buy |
+47,500
| New | +$166K | 0.01% | 230 |
|